Yuwen Qi

1.9k total citations
16 papers, 158 citations indexed

About

Yuwen Qi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuwen Qi has authored 16 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Yuwen Qi's work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Yuwen Qi is often cited by papers focused on RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Yuwen Qi collaborates with scholars based in China, Singapore and New Zealand. Yuwen Qi's co-authors include Yang Gao, Jingbo Gao, Xu Liu, Yanqi He, Lei Wei, Yanbing Ma, Wenting Pan, Kai Li, Ming-Bai Hu and Xiaolong Xu and has published in prestigious journals such as Frontiers in Immunology, Cancer Letters and BioMed Research International.

In The Last Decade

Yuwen Qi

14 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuwen Qi China 8 74 66 40 32 32 16 158
Junhee Yoon United States 8 68 0.9× 66 1.0× 26 0.7× 61 1.9× 40 1.3× 12 160
Junyan Yu China 8 87 1.2× 57 0.9× 36 0.9× 16 0.5× 22 0.7× 19 141
Yunkun Lu China 8 183 2.5× 98 1.5× 25 0.6× 34 1.1× 17 0.5× 19 249
Raheleh Amirkhah Iran 8 186 2.5× 152 2.3× 40 1.0× 18 0.6× 13 0.4× 15 254
Laura Battista Switzerland 5 61 0.8× 47 0.7× 78 1.9× 9 0.3× 14 0.4× 10 159
Shangqian Wang China 7 130 1.8× 84 1.3× 79 2.0× 33 1.0× 80 2.5× 10 229
Kenji M. Fujihara Australia 11 175 2.4× 61 0.9× 71 1.8× 17 0.5× 57 1.8× 15 253
Rongli Wei China 4 78 1.1× 65 1.0× 47 1.2× 8 0.3× 18 0.6× 7 140
Vanina Toffessi Tcheuyap United States 7 88 1.2× 52 0.8× 26 0.7× 10 0.3× 58 1.8× 13 150

Countries citing papers authored by Yuwen Qi

Since Specialization
Citations

This map shows the geographic impact of Yuwen Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwen Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwen Qi more than expected).

Fields of papers citing papers by Yuwen Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwen Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwen Qi. The network helps show where Yuwen Qi may publish in the future.

Co-authorship network of co-authors of Yuwen Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwen Qi. A scholar is included among the top collaborators of Yuwen Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwen Qi. Yuwen Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Qi, Yuwen, Ying Li, Hua Wang, et al.. (2024). Natural killer cell‐related anti‐tumour adoptive cell immunotherapy. Journal of Cellular and Molecular Medicine. 28(11). e18362–e18362. 6 indexed citations
3.
Qi, Yuwen, Shen Yin, Yaxing Zhang, et al.. (2024). Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients. Aging. 16(1). 207–225. 2 indexed citations
4.
Shen, Jie, et al.. (2023). Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer. Frontiers in Immunology. 14. 1268251–1268251. 3 indexed citations
6.
Qi, Yuwen, et al.. (2023). An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer. Frontiers in Oncology. 13. 1194100–1194100. 1 indexed citations
7.
Chen, Zhiwei, et al.. (2023). Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells. Translational Oncology. 37. 101778–101778. 7 indexed citations
9.
Yao, Shijie, Yuan Cheng, Yuying Shi, et al.. (2022). Alternative Splicing: A New Therapeutic Target for Ovarian Cancer. Technology in Cancer Research & Treatment. 21. 2203809799–2203809799. 6 indexed citations
10.
Qi, Yuwen, Jiqin Han, Nicola M. Shadbolt, & Qing Zhang. (2022). Can the use of digital technology improve the cow milk productivity in large dairy herds? Evidence from China's Shandong Province. Frontiers in Sustainable Food Systems. 6. 8 indexed citations
12.
Diao, Lijun, et al.. (2022). An Optimization of New Energy Hybrid Configuration Parameters Based on GA Method. Journal of Marine Science and Engineering. 10(11). 1747–1747. 7 indexed citations
14.
Ma, Qing, Yang Gao, Pei Xu, et al.. (2019). Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB). BioMed Research International. 2019. 1–15. 33 indexed citations
15.
Li, Kai, Xiaolong Xu, Yanqi He, et al.. (2018). P21-activated kinase 7 (PAK7) interacts with and activates Wnt/β-catenin signaling pathway in breast cancer. Journal of Cancer. 9(10). 1821–1835. 24 indexed citations
16.
Hu, Ming-Bai, Jingbo Gao, Yuwen Qi, et al.. (2018). Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells. Ultrastructural Pathology. 42(5). 409–415. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026